Please login to the form below

The changing face of physician needs

Understanding physician perspectives on scientific meetings, how meetings are changing and future challenges for pharma companies.

As part of their overall learning journey, healthcare professionals (HCPs) attend scientific meetings to expand their knowledge, connect with peers, listen to thought-leaders and discuss new advances in treatment.

Surveys consistently reveal that scientific meetings feature in the top three preferred channels for HCP medical education. But will that always be the case?

With changes in legislation and shifts in technology that facilitate remote learning, will HCPs continue to travel halfway around the globe for a scientific meeting, advisory board or standalone meeting, taking precious days away from their practice?

Or will they become increasingly selective, looking for alternative medical education channels and only attending meetings in person known to deliver a return on their objectives and time?

These questions point to trends which look set to continue for the foreseeable future.

Our aim has been to find out what drives HCPs to attend scientific meetings, what criteria they use in evaluating their value, and how they see the scientific meetings of the future evolving.

Download this white paper here to further understand the research and analysis we conducted and how you can engage with HCPs effectively when looking at the future of meetings.

This article has been published by Ashfield Meetings & Events

12th May 2016



Company Details


Contact Website

Ashfield House
Resolution Road
Ashby de la Zouch
LE65 1HW

Latest content on this profile

Ashfield wins Best Newcomer at the Pf Awards 2018
We are thrilled to announce that Zuchaela Smylie, from Ashfield, won Best Newcomer at the 2018 Pf Awards, the largest pharmaceutical sales awards in the UK. The awards ceremony took place on Thursday, 9 March at The Lancaster Hotel in London.
“It is evident that meeting face-to-face is still highly valued in the digital age”
Attending a scientific congress or meeting overtakes professional journals and publications as the educational channel of choice for Healthcare Professionals – according to findings of new study
Ashfield to present at the Orphan Drugs for Rare Diseases Summit
Ashfield has a breadth of experience with orphan drugs and we are passionate about helping to improve the lives of people living with rare diseases. We are delighted to be sponsoring and presenting at the ‘Orphan Drugs for Rare Diseases’ event 22-23 March in Berlin.
Addressing the biggest challenges for rare disease communities
Each year, Rare Disease Day takes place worldwide on the last day in February. The main objective of Rare Disease Day is to raise awareness amongst the general public, the healthcare industry and decision-makers about rare diseases and their impact on patients' lives.
Humanise is our strategic approach to healthcare communications. It’s based on the need to understand. It looks at the emotions that make us human. It examines the feelings we have as individuals. It defines the behaviours we show as people.
Ashfield launches new commercial model to improve ROI
Ashfield, part of UDG Healthcare, a global leader in providing outsourced healthcare services, has announced the launch of a pioneering new commercial model called The Ashfield Solution.